Liposomes or Extracellular Vesicles: A Comprehensive Comparison of Both Lipid Bilayer Vesicles for Pulmonary Drug Delivery

QRコード

Liposomes or Extracellular Vesicles: A Comprehensive Comparison of Both Lipid Bilayer Vesicles for Pulmonary Drug Delivery

The rapid and non-invasive pulmonary drug delivery (PDD) has attracted great attention compared to the other routes. However, nanoparticle platforms, like liposomes (LPs) and extracellular vesicles (EVs), require extensive reformulation to suit the requirements of PDD. LPs are artificial vesicles co...

書誌詳細
出版年:	Polymers
第一著者:	Al-Jipouri A.; Almurisi S.H.; Al-Japairai K.; Bakar L.M.; Doolaanea A.A.
フォーマット:	Review
言語:	English
出版事項:	MDPI 2023
オンライン･アクセス:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85146570265&doi=10.3390%2fpolym15020318&partnerID=40&md5=42f05959292e0a26c6675f6c3e8fc17a

類似資料

Umbilical Cord Mesenchymal Stromal Cell-Derived Small Extracellular Vesicles Modulate Skin Matrix Synthesis and Pigmentation
著者:: Kee L.T.; Foo J.B.; How C.W.; Azurah A.G.N.; Chan H.H.; Yunus M.H.M.; Ng S.N.; Ng M.H.; Law J.X.
出版事項: (2025)

Umbilical Cord Mesenchymal Stromal Cell-Derived Small Extracellular Vesicles Modulate Skin Matrix Synthesis and Pigmentation
著者:: 2-s2.0-85217961600
出版事項: (2025)

Effect of 3D and 2D cell culture systems on trophoblast extracellular vesicle physico-chemical characteristics and potency
著者:: Khan N.L.A.; Muhandiram S.; Dissanayake K.; Godakumara K.; Midekessa G.; Andronowska A.; Heath P.R.; Kodithuwakku S.; Hart A.R.; Fazeli A.
出版事項: (2024)

Transcorneal drug delivery: Prospects for the use of liposomes
著者:: 2-s2.0-84925547404
出版事項: (2014)

Palm oil in lipid-based formulations and drug delivery systems
著者:: 2-s2.0-85061870178
出版事項: (2019)

Engineered liposomes mediated approach for targeted colorectal cancer drug Delivery: A review
著者:: 2-s2.0-85181882337
出版事項: (2024)

Chitosan-Based Nanocarriers for Pulmonary and Intranasal Drug Delivery Systems: A Comprehensive Overview of their Applications
著者:: 2-s2.0-85196714137
出版事項: (2024)

Critical parameters for particle-based pulmonary delivery of chemotherapeutics
著者:: 2-s2.0-85048392934
出版事項: (2018)

CoLipid: A Mobile Application for Lipid Monitoring
著者:: Sia Abdullah N.A.; Rosli M.M.; Abd Aziz N.D.; Mohd Kasim N.A.
出版事項: (2024)

Critical physicochemical and biological attributes of nanoemulsions for pulmonary delivery of rifampicin by nebulization technique in tuberculosis treatment
著者:: Shah K.; Chan L.W.; Wong T.W.
出版事項: (2017)

Functionalized chitosan for cancer nano drug delivery
著者:: 2-s2.0-85166736087
出版事項: (2023)

A review on chitosan and its development as pulmonary particulate anti-infective and anti-cancer drug carriers
著者:: 2-s2.0-85089817995
出版事項: (2020)

Electrospun Nanofiber Composites for Drug Delivery: A Review on Current Progresses
著者:: Jiffrin R.; Razak S.I.A.; Jamaludin M.I.; Hamzah A.S.A.; Mazian M.A.; Jaya M.A.T.; Nasrullah M.Z.; Majrashi M.; Theyab A.; Aldarmahi A.A.; Awan Z.; Abdel-Daim M.M.; Azad A.K.
出版事項: (2022)

Reinvention of starch for oral drug delivery system design
著者:: 2-s2.0-85153496947
出版事項: (2023)

Drug nanocarrier, the future of atopic diseases: Advanced drug delivery systems and smart management of disease
著者:: 2-s2.0-84984782982
出版事項: (2016)

Vitreous Humor: Composition, Characteristics and Implication on Intravitreal Drug Delivery
著者:: Mishra D.; Gade S.; Glover K.; Sheshala R.; Singh T.R.R.
出版事項: (2023)

Vitreous Humor: Composition, Characteristics and Implication on Intravitreal Drug Delivery
著者:: 2-s2.0-85142898832
出版事項: (2023)

Nanocarriers and their actions to improve skin permeability and transdermal drug delivery
著者:: 2-s2.0-84930903657
出版事項: (2015)

Electrospun Nanofiber Composites for Drug Delivery: A Review on Current Progresses
著者:: 2-s2.0-85138799792
出版事項: (2022)

Biomimetic Supramolecular Polymer Networks Exhibiting both Toughness and Self-Recovery
著者:: Liu J.; Tan C.S.Y.; Yu Z.; Lan Y.; Abell C.; Scherman O.A.
出版事項: (2017)

In vitro dissolution testing models of ocular implants for posterior segment drug delivery
著者:: Adrianto M.F.; Annuryanti F.; Wilson C.G.; Sheshala R.; Thakur R.R.S.
出版事項: (2022)

In vitro dissolution testing models of ocular implants for posterior segment drug delivery
著者:: 2-s2.0-85112306162
出版事項: (2022)

Lipids as key biomarkers in unravelling the pathophysiology of obesity-related metabolic dysregulation
著者:: Osman A.A.; Chin S.-F.; Teh L.-K.; Abdullah N.; Abdul Murad N.A.; Jamal R.
出版事項: (2025)

Biomimetic Supramolecular Polymer Networks Exhibiting both Toughness and Self-Recovery
著者:: 2-s2.0-85009829107
出版事項: (2017)

Medium-Chain Triacylglycerols (MCTs) and Their Fractions in Drug Delivery Systems : A Systematic Review
著者:: 2-s2.0-85186758846
出版事項: (2024)

Relationship between coping styles and lipid profile among public university staff
著者:: Ariaratnam S.; Krishnapillai A.D.; Daher A.M.; Fadzil M.A.; Razali S.; Omar S.A.; Keat N.K.; Mat Nasir N.; Miskan M.; Md Yasin M.; Saw J.A.; Durairajanayagam D.; Kaur G.; Che Bakar O.; Hashim N.A.
出版事項: (2017)

Drug safety in Malaysia
著者:: Elkalmi R.M.; Al-Worafi Y.M.; Alseragi W.M.; Ming L.C.; Siddique A.
出版事項: (2020)

Thematic analysis of perceptions from both patients and dental students on a digital clinical decision aid in prosthodontics: A qualitative study
著者:: Lim, 等
出版事項: (2025)

Release behavior and cytotoxicity of captopril-intercalated layered double hydroxide for an antihypertensive drug delivery system
著者:: Jadam M.L.; Jubri Z.; Sarijo S.H.
出版事項: (2023)

Recent updates on novel approaches in insulin drug delivery: A review of challenges and pharmaceutical implications
著者:: 2-s2.0-85055902053
出版事項: (2018)

Impact of chitosan composites and chitosan nanoparticle composites on various drug delivery systems: A review
著者:: 2-s2.0-84920059808
出版事項: (2015)

Numerical analysis of MgF2/SiO2 bilayers anti-reflective coating of light trapping in silicon solar cells by ray tracer software
著者:: 2-s2.0-85136099897
出版事項: (2022)

Effectiveness of a pharmacist-led tele-psychiatric clinic in managing drug-related problems
著者:: Al Shakhori M.; Arain S.; Abdulsalim S.; Salim Karattuthodi M.; Al Dhamen M.; Almutairi S.; Thorakkattil S.A.; Alahmdi D.; Kunhikatta V.; AlJishi A.S.
出版事項: (2025)

Dielectric properties of a ready-to-use therapeutic food material composed of lipids
著者:: 2-s2.0-85153483184
出版事項: (2023)

A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB
著者:: Tweed C.D.; Wills G.H.; Crook A.M.; Amukoye E.; Balanag V.; Ban A.Y.L.; Bateson A.L.C.; Betteridge M.C.; Brumskine W.; Caoili J.; Chaisson R.E.; Cevik M.; Conradie F.; Dawson R.; del Parigi A.; Diacon A.; Everitt D.E.; Fabiane S.M.; Hunt R.; Ismail A.I.; Lalloo U.; Lombard L.; Louw C.; Malahleha M.; McHugh T.D.; Mendel C.M.; Mhimbira F.; Moodliar R.N.; Nduba V.; Nunn A.J.; Sabi I.; Sebe M.A.; Selepe R.A.P.; Staples S.; Swindells S.; van Niekerk C.H.; Variava E.; Spigelman M.; Gillespie S.H.
出版事項: (2021)

The State of the Art of Natural Polymer Functionalized Fe3O4 Magnetic Nanoparticle Composites for Drug Delivery Applications: A Review
著者:: Nordin A.H.; Ahmad Z.; Husna S.M.N.; Ilyas R.A.; Azemi A.K.; Ismail N.; Nordin M.L.; Ngadi N.; Siti N.H.; Nabgan W.; Norfarhana A.S.; Azami M.S.M.
出版事項: (2023)

Central composite design for formulation and optimization of solid lipid nanoparticles to enhance oral bioavailability of acyclovir
著者:: 2-s2.0-85114598330
出版事項: (2021)

Effectiveness of home-based pulmonary rehabilitation: systematic review and meta-analysis
著者:: 2-s2.0-85138302325
出版事項: (2022)

A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB
著者:: 2-s2.0-85103500407
出版事項: (2021)

Polyamidoamine dendrimers can improve the pulmonary absorption of insulin and calcitonin in rats
著者:: 2-s2.0-79952224936
出版事項: (2011)